These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 10914623)

  • 41. The HELLP syndrome: its association with unexplained elevation of MSAFP and MShCG in the second trimester.
    Morssink LP; Heringa MP; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1997 Jul; 17(7):601-6. PubMed ID: 9249859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
    Spencer K
    Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol.
    Heyl PS; Miller W; Canick JA
    Obstet Gynecol; 1990 Dec; 76(6):1025-31. PubMed ID: 1700348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Unexplained increase in maternal plasma in alpha-fetoproteins in the second trimester of pregnancy: perinatal results].
    Cox M U; Kingdom J; Whittle M; McNay M; Fleming J; Bowman A; Crossley J; Aitken D
    Rev Chil Obstet Ginecol; 1995; 60(3):174-80. PubMed ID: 8728745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early detection of preeclampsia using inhibin a and other second-trimester serum markers.
    Ree PH; Hahn WB; Chang SW; Jung SH; Kang JH; Cha DH; Kang MS; Huh JY
    Fetal Diagn Ther; 2011; 29(4):280-6. PubMed ID: 21252475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fetal gender impact on multiple-marker screening results.
    Bazzett LB; Yaron Y; O'Brien JE; Critchfield G; Kramer RL; Ayoub M; Johnson MP; Evans MI
    Am J Med Genet; 1998 Apr; 76(5):369-71. PubMed ID: 9556293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Race-ethnicity-specific variation in multiple-marker biochemical screening: alpha-fetoprotein, hCG, and estriol.
    O'Brien JE; Dvorin E; Drugan A; Johnson MP; Yaron Y; Evans MI
    Obstet Gynecol; 1997 Mar; 89(3):355-8. PubMed ID: 9052584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relationship between perinatal outcome of singleton pregnancies and isolated highly elevated levels of maternal serum human chorionic gonadotropin at mid-gestation.
    Tavor O; Shohat M; Lipitz S
    Isr Med Assoc J; 2007 Jul; 9(7):509-12. PubMed ID: 17710780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects.
    Jelliffe-Pawlowski LL; Walton-Haynes L; Currier RJ
    Prenat Diagn; 2009 Jun; 29(6):570-7. PubMed ID: 19266536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The detection of non-immune hydrops through second-trimester maternal serum screening.
    Saller DN; Canick JA; Oyer CE
    Prenat Diagn; 1996 May; 16(5):431-5. PubMed ID: 8844001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maternal serum screening for birth defects: results of a Connecticut regional program.
    Benn PA; Horne D; Craffey A; Collins R; Ramsdell L; Greenstein R
    Conn Med; 1996 Jun; 60(6):323-7. PubMed ID: 8706425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased maternal serum human chorionic gonadotropin concentrations are an independent risk factor for SGA in dichorionic twin gestations.
    Hershkovitz R; Bar G; Erez O; Smolin A; Sheiner E; Mishori-Dery A; Mazor M
    J Matern Fetal Neonatal Med; 2005 Aug; 18(2):117-22. PubMed ID: 16203597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Relationship of adverse pregnancy outcomes and a high risk serum screen for Down syndrome in the second trimester].
    Hu XY; Bian XM; Jiang YL; Liu SY
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):427-30. PubMed ID: 22932108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
    Wenstrom KD; Owen J; Davis RO; Brumfield CG
    Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between maternal serum alpha-fetoprotein and maternal haemoglobin.
    Bartha JL; Omar KM; Soothill PW
    Prenat Diagn; 2004 Aug; 24(8):609-12. PubMed ID: 15305347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses.
    Spencer K; Cowans NJ; Avgidou K; Molina F; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jan; 31(1):15-9. PubMed ID: 17999381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women.
    Sritippayawan S; Vachirasrisoontra C
    J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
    Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
    Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes.
    Chandra S; Scott H; Dodds L; Watts C; Blight C; Van Den Hof M
    Am J Obstet Gynecol; 2003 Sep; 189(3):775-81. PubMed ID: 14526312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.